Department of Electrocardiology John Paul II Hospital in Krakow.
Department of Anatomy, Jagiellonian University Medical College, Krakow.
Cardiol J. 2019;26(6):717-726. doi: 10.5603/CJ.a2018.0093. Epub 2018 Aug 29.
Dual-chamber (DDD) pacing is the most widely utilised pacing modality in many parts of the world. The present study aimed to evaluate life expectancy of DDD pacemaker patients in comparison to the age- and sex-matched general population, assess changes in baseline characteristics over three decades of the inclusion period and determine the association between selected variables and patient survival.
This longitudinal study of consecutive de novo DDD pacemaker implantations performed between 1984 and 2014, with all-cause mortality until 2016 as the endpoint, was conducted at a singlecenter university hospital.
Under assessment were 3928 patients with a total of 30,087 patient-years of survival time. Compared to the general population, the observed survival was significantly inferior until 12 years post DDD pacemaker implant (HR = 1.499, p < 0.001), whereas after 12 years of follow-up the observed survival was significantly superior (HR = 0.555, p < 0.001). A comparison of patient baseline characteristics over three decades revealed the following significant changes: more elderly patients, more female patients, less patients with atrioventricular block, more patients with atrial fibrillation/atrial flutter (AF/AFL) and fewer patients with an apical right ventricular (RV) lead position in the later decades. In multivariate analysis male sex and higher age were the only variables significantly associated with shorter survival time. Indication for pacing, history of pre-implant AF/AFL, RV lead position and device infection were not associated with survival.
In the very-long-term follow-up of DDD pacemaker patients, the parameters associated with survival were sex and baseline age at first implantation.
双腔(DDD)起搏是世界上许多地区应用最广泛的起搏方式。本研究旨在评估与年龄和性别匹配的普通人群相比,DDD 起搏器患者的预期寿命,评估在纳入期的三十年中基线特征的变化,并确定选定变量与患者生存之间的关系。
这是一项在单中心大学医院进行的连续研究,对 1984 年至 2014 年间进行的新诊断的 DDD 起搏器植入患者进行评估,以全因死亡率作为 2016 年的终点。
共评估了 3928 例患者,共 30087 患者年的生存时间。与普通人群相比,DDD 起搏器植入后 12 年内观察到的生存率明显较低(HR=1.499,p<0.001),而 12 年随访后观察到的生存率明显较高(HR=0.555,p<0.001)。对 30 年来患者基线特征的比较显示出以下显著变化:更多的老年患者,更多的女性患者,较少的房室传导阻滞患者,更多的心房颤动/心房扑动(AF/AFL)患者,较少的心尖右心室(RV)导线位置患者。多变量分析显示,男性和较高的年龄是与较短生存时间唯一显著相关的变量。起搏指征、植入前 AF/AFL 病史、RV 导线位置和器械感染与生存无关。
在 DDD 起搏器患者的长期随访中,与生存相关的参数是首次植入时的性别和基础年龄。